Gainers
- ContraFect CFRX stock increased by 4.9% to $2.76 during Thursday's after-market session. The company's market cap stands at $108.5 million.
- Lexaria Bioscience LEXX shares moved upwards by 4.76% to $4.51. The company's market cap stands at $26.8 million.
- Atossa Therapeutics ATOS shares increased by 4.57% to $1.6. The market value of their outstanding shares is at $202.5 million.
- Enveric Biosciences ENVB stock increased by 4.42% to $0.9. The market value of their outstanding shares is at $29.4 million.
- Quoin Pharmaceuticals QNRX stock rose 4.02% to $1.81. The market value of their outstanding shares is at $15.1 million.
- Chembio Diagnostics CEMI stock rose 3.66% to $1.13. The company's market cap stands at $33.9 million.
Losers
- Plus Therapeutics PSTV shares fell 6.8% to $1.23 during Thursday's after-market session. Today's trading volume for this security ended up closing at 103.7K shares, which is 4.2 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $18.8 million.
- Graphite Bio GRPH shares declined by 6.23% to $10.4. The market value of their outstanding shares is at $604.0 million.
- Ikena Oncology IKNA stock declined by 5.43% to $11.5. The market value of their outstanding shares is at $412.9 million.
- China SXT Pharmaceuticals SXTC stock fell 5.04% to $0.51. The company's market cap stands at $7.8 million.
- BiondVax Pharmaceuticals BVXV stock declined by 4.88% to $1.95. The company's market cap stands at $36.0 million.
- Ensysce Biosciences ENSC stock fell 4.64% to $4.53. Trading volume for this security closed at 137.7K, accounting for 2.1% of its average full-day volume over the last 100 days. The company's market cap stands at $109.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in